CDKN2A and metastatic neoplasm: Second, although CDKN2A ALT was inversely associated with the OS of patients treated without ICIs and positively associated with the OS of patients, especially patients having metastatic disease, treated with ICIs, the relationship and underlying mechanisms behind this association need to be further assessed.